Digital therapeutics: where are we standing and what’s next in the EU and the US?
21 Mar 2024
Session information
Digital therapeutics: where are we standing and what’s next in the EU and the US?
Thursday 21 March (1231 - 1359)
Committee(s)
Healthcare and Life Sciences Law Committee
(Lead)
Session / Workshop Chair(s)
| Koen T'Syen | Van Bael & Bellis, Brussels, Belgium |
Speakers
| Massimo Beccaria | Advice Pharma Group , Milan, Italy |
| Yuri Maricich | former CMO of Pear Therapeutics, Boston, Massachusetts, USA |
| Allyson Mullen | Hyman, Phelps & McNamara, Washington, District of Columbia, USA |
| Janine Reudt-Demont | Niederer Kraft Frey AG, Zürich, Switzerland |
| Elisa Stefanini | Portolano Cavallo, Rome, Italy; Technology Law Committee Liaison Officer, Healthcare and Life Sciences Law Committee |
| Cecile Theard-Jallu | De Gaulle Fleurance, Paris, France; Co-Chair, Healthcare and Life Sciences Law Committee |
| Vincent Vercamer | French Ministry of Health and Prevention, Paris, France |